Multimodal population brain imaging in the UK Biobank prospective epidemiological study
- PMID: 27643430
- PMCID: PMC5086094
- DOI: 10.1038/nn.4393
Multimodal population brain imaging in the UK Biobank prospective epidemiological study
Abstract
Medical imaging has enormous potential for early disease prediction, but is impeded by the difficulty and expense of acquiring data sets before symptom onset. UK Biobank aims to address this problem directly by acquiring high-quality, consistently acquired imaging data from 100,000 predominantly healthy participants, with health outcomes being tracked over the coming decades. The brain imaging includes structural, diffusion and functional modalities. Along with body and cardiac imaging, genetics, lifestyle measures, biological phenotyping and health records, this imaging is expected to enable discovery of imaging markers of a broad range of diseases at their earliest stages, as well as provide unique insight into disease mechanisms. We describe UK Biobank brain imaging and present results derived from the first 5,000 participants' data release. Although this covers just 5% of the ultimate cohort, it has already yielded a rich range of associations between brain imaging and other measures collected by UK Biobank.
Conflict of interest statement
PW and ID are employees of Siemens Healthcare UK, the vendor of MRI scanners for UK Biobank selected under a competitive bidding process. Other authors declare no competing financial interests.
Figures
References
-
- Allen N, et al. UK Biobank: Current status and what it means for epidemiology. Health Policy and Technology. 2012;1:123–126.
-
- Wick J. Understanding frailty in the geriatric population. Consult Pharm. 2011;26:634–645. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
